<?xml version="1.0" encoding="utf-8" standalone="yes"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>结核 on Hugo Prose</title>
    <link>/tags/%E7%BB%93%E6%A0%B8/</link>
    <description>Recent content in 结核 on Hugo Prose</description>
    <generator>Hugo -- gohugo.io</generator>
    <language>en-us</language>
    <lastBuildDate>Fri, 11 Sep 2015 00:00:00 +0000</lastBuildDate><atom:link href="/tags/%E7%BB%93%E6%A0%B8/index.xml" rel="self" type="application/rss+xml" />
    <item>
      <title>InbR, a TetR family regulator, binds with isoniazid and influences multidrug resistance in Mycobacterium bovis BCG</title>
      <link>/post/2015/09/11/2015-09-11-inbr-paper/</link>
      <pubDate>Fri, 11 Sep 2015 00:00:00 +0000</pubDate>
      
      <guid>/post/2015/09/11/2015-09-11-inbr-paper/</guid>
      <description>在Scientific Reports上面的一篇论文昨天（2015-9-10）上线了。我是第二作者，负责了ChIP-seq实验等少部分实验，全部的生物信息学分析，论文撰写、修订和投稿等事宜。该研究最初投稿的是核酸研究杂志，被拒稿后由我接手，转投Scientific Reports，前后耗费了2个多月终于接受。除了正文中，附件也有不少数据，特别是一个大Table。
http://www.nature.com/articles/srep13969
论文摘要如下：
Isoniazid (INH), an anti-tuberculosis (TB) drug, has been widely used for nearly 60 years. However, the pathway through which Mycobacterium tuberculosis responds INH remain largely unclear. In this study, we characterized a novel transcriptional factor, InbR, which is encoded by Rv0275c and belongs to the TetR family, that is directly responsive to INH. Disrupting inbR made mycobacteria more sensitive to INH, whereas overexpressing inbR decreased bacterial susceptibility to the drug.</description>
    </item>
    
    <item>
      <title>抗结核新药研发进程</title>
      <link>/post/2011/02/17/2011-02-17-anti-tb-drugs/</link>
      <pubDate>Thu, 17 Feb 2011 00:00:00 +0000</pubDate>
      
      <guid>/post/2011/02/17/2011-02-17-anti-tb-drugs/</guid>
      <description>在2011年1月的Nature上，总结了抗结核新药的研发进程。已经有个别药物进入III期临床试验，相信快要面世啦。
Koul, A., Arnoult, E., Lounis, N., Guillemont, J. &amp;amp; Andries, K. The challenge of new drug discovery for tuberculosis. Nature 469, 483-490 (2011).</description>
    </item>
    
  </channel>
</rss>
